CCP
TVGNW icon

Corbin Capital Partners’s Tevogen Bio Warrant TVGNW Stock Holding History

Corbin Capital Partners’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$62.6K Hold
1,160,000
– – 0.1% 15
2024
Q3 		$15K Hold
1,160,000
– – 0.02% 21
2024
Q2 		$75.4K Hold
1,160,000
– – 0.15% 20
2024
Q1 		$95.7K Sell
1,160,000
-858,400
-43% -$51.4K 0.16% 22
2023
Q4 		$80.7K Buy
2,018,400
+858,400
+74% +$34.9K 0.34% 18
2023
Q3 		$58K Hold
1,160,000
– – 0.09% 25
2023
Q2 		$47.9K Hold
1,160,000
– – 0.04% 40
2023
Q1 		$92.8K Hold
1,160,000
– – 0.05% 44
2022
Q4 		$3.6K Hold
1,160,000
– – ﹤0.01% 92
2022
Q3 		$139K Hold
1,160,000
– – 0.03% 66
2022
Q2 		$186K Hold
1,160,000
– – 0.04% 69
2022
Q1 		$313K Buy
+1,160,000
New +$431K 0.05% 78

Other funds holding TVGNW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Corbin Capital Partners's TVGNW Position: Q4 2024 in Review

Corbin Capital Partners held its Tevogen Bio Warrant (TVGNW) position steady in Q4 2024 at 1,160,000 shares worth $62.6K. The position accounts for 0.1% of the portfolio, ranked #15.

Corbin Capital Partners first reported a position in TVGNW in Q1 2022 and has held it in 12 quarters since. The position peaked at $313K in Q1 2022. 36 funds tracked by Wall St. Rank hold TVGNW as of Q4 2024.

  • Corbin Capital Partners held 1,160,000 shares of Tevogen Bio Warrant worth $62.6K as of Q4 2024.
  • Corbin Capital Partners left its Tevogen Bio Warrant share count unchanged in Q4 2024.
  • Tevogen Bio Warrant made up 0.1% of Corbin Capital Partners's portfolio in Q4 2024, its #15 holding.
  • Corbin Capital Partners first reported a position in Tevogen Bio Warrant in Q1 2022 and has held it in 12 quarters since.
  • Corbin Capital Partners's Tevogen Bio Warrant position peaked at $313K in Q1 2022.
  • 36 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q4 2024.

Based on Corbin Capital Partners's 13F filing for Q4 2024, filed 11 Feb 2025.